Trial intelligence / Profile preview

Gabapentin for cannabis dependence

NCT00395044Phase 2Completed

Sponsor
Scripps Research
Start
Aug 2006
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gabapentin in cannabis use disorder (CUD), sponsored by Scripps Research. Started Aug 2006; status: completed.

02

Drugs

gabapentin
03

Conditions

cannabis use disorder (CUD)

Beyond the preview

Go deeper on NCT00395044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00395044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call